Annual report pursuant to Section 13 and 15(d)

NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING AND REPORTING POLICIES (Tables)

v3.24.3
NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING AND REPORTING POLICIES (Tables)
12 Months Ended
Jun. 30, 2024
Accounting Policies [Abstract]  
SCHEDULE OF TRANSACTION EXCHANGE RATES

As of June 30, 2024 and 2023, the exchange rates used to translate amounts in Australian dollars into USD for the purposes of preparing the consolidated financial statements were as follows:

 

    June 30, 2024     June 30, 2023  
Exchange rate on balance sheet dates                
USD : AUD exchange rate     0.6693       0.6664  
                 
Average exchange rate for the period                
USD : AUD exchange rate     0.6557       0.6732  
SCHEDULE OF ACCUMULATED OTHER COMPREHENSIVE INCOME LOSS

Change in Accumulated Other Comprehensive Income (Loss) by component during the years ended June 30, 2024 and 2023 were as follows:

 

   

Foreign

Currency Items:

 
Beginning balance, June 30, 2022   $ 1,234,549  
Foreign currency translation gain     60,327  
Balance, June 30, 2023     1,294,876  
Foreign currency translation loss     (25,295 )
Ending balance, June 30, 2024   $ 1,269,581  
SCHEDULE OF PROPERTY AND EQUIPMENT ESTIMATED USEFUL LIVES

The estimated useful lives are as follows:

 

Machinery and equipment - 5 years
Furniture - 7 years
SCHEDULE OF ANTI-DILUTIVE SECURITIES EXCLUDED FROM COMPUTATION OF EARNINGS

 

    June 30, 2024     June 30, 2023  
             
Stock Options     0.06       0.06  
Warrants with no designations     15,003,396       90  
Series A Warrants as if converted at alternate cashless exercise prices     1,990,353,990       1,996,625,990  
Series B Warrants     16       16  
Series C Warrants as if converted at alternate cashless exercise prices *     9,175,999,954       9,473,999,953  
Unvested restricted stock units     0.06       0.06  
Convertible Debt     393,727,811       5,991,195  
Total     11,575,085,167.12       11,476,617,244.12  

 

* Only convertible ratably upon exercise of Series B Warrants